ArticleNature communications2023
Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.
Abstract readPublished Erratum
In one paragraph
Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanisms and technologies in cancer epigenetics.Frontiers in oncology · 2024Review
Corrections and comments
- Erratum for
Authors and funding
42 authors.
Yige Wu *Oncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Nadezhda V Terekhanova *Oncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Wagma Caravan *Oncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.ORCID http://orcid.org/0000-0003-4082-6723
Nataly Naser Al Deen *Oncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Preet Lal *Oncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Siqi ChenOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Chia-Kuei MoOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Song CaoOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Yize LiOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.ORCID http://orcid.org/0000-0003-1074-281X
Alla KarpovaOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Ruiyang LiuOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Yanyan ZhaoOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Andrew ShinkleOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Ilya StrunilinOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Cody WeimholtDepartment of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Kazuhito SatoOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.ORCID http://orcid.org/0000-0003-0589-7454
Lijun YaoOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Mamatha SerasanambatiOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Xiaolu YangOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.ORCID http://orcid.org/0000-0003-4749-7803
Matthew WyczalkowskiOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.ORCID http://orcid.org/0000-0003-4197-551X
Houxiang ZhuOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Daniel Cui ZhouOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.ORCID http://orcid.org/0000-0002-7834-2778
Reyka G JayasingheOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.ORCID http://orcid.org/0000-0003-2368-4890
Daniel MendezOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Michael C WendlOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
David ClarkDepartment of Pathology, Johns Hopkins University, Baltimore, MD, 21231, USA.
Chelsea NewtonVan Andel Institutes, Grand Rapids, MI, 49503, USA.
Yijun RuanThe Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT, 06032, USA.
Melissa A ReimersOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Russell K PachynskiOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Chris KinsingerOffice of Cancer Clinical Proteomics Research, National Cancer Institute, Bethesda, MD, 20892, USA.
Scott JewellVan Andel Institutes, Grand Rapids, MI, 49503, USA.ORCID http://orcid.org/0000-0001-9469-6261
Daniel W ChanDepartment of Pathology, Johns Hopkins University, Baltimore, MD, 21231, USA.
Hui ZhangDepartment of Pathology, Johns Hopkins University, Baltimore, MD, 21231, USA.ORCID http://orcid.org/0000-0001-8726-7098
Aadel A ChaudhuriDepartment of Genetics, Washington University in St. Louis, St. Louis, MO, 63110, USA.ORCID http://orcid.org/0000-0003-3115-3061
Milan G ChhedaOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.ORCID http://orcid.org/0000-0001-8282-9098
Benjamin D HumphreysOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.ORCID http://orcid.org/0000-0002-6420-8703
Mehdi MesriOffice of Cancer Clinical Proteomics Research, National Cancer Institute, Bethesda, MD, 20892, USA.
Henry RodriguezOffice of Cancer Clinical Proteomics Research, National Cancer Institute, Bethesda, MD, 20892, USA.
James J HsiehOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA.ORCID http://orcid.org/0000-0003-3595-0551
Li DingOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA. lding@wustl.edu.ORCID http://orcid.org/0000-0003-1517-2975
Feng ChenOncology Division, Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110, USA. fchen@wustl.edu.ORCID http://orcid.org/0000-0002-2307-7954
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.